Biorphen

— THERAPEUTIC CATEGORIES —
  • Hypotension

Biorphen Generic Name & Formulations

General Description

Phenylephrine HCl 0.1mg/mL; soln for IV inj.

Pharmacological Class

Sympathomimetic.

How Supplied

Ampules (5mL)—10

Biorphen Indications

Indications

Treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia.

Biorphen Dosage and Administration

Adult

Initially 40–100mcg by IV bolus, additional doses may be administered every 1–2 minutes as needed; up to max total dose of 200mcg.

Children

Not established.

Biorphen Contraindications

Not Applicable

Biorphen Boxed Warnings

Not Applicable

Biorphen Warnings/Precautions

Warnings/Precautions

Exacerbation of angina (in those with severe arteriosclerosis or history of angina). Heart failure. Pulmonary arterial hypertension. Extensive peripheral vascular disease. Monitor renal function. ESRD. Autonomic dysfunction (eg, spinal cord injury). Avoid extravasation. Elderly. Pregnancy. Nursing mothers.

Biorphen Pharmacokinetics

See Literature

Biorphen Interactions

Interactions

Potentiated by oxytocic drugs, tricyclic antidepressants, MAOIs, angiotensin, aldosterone, atropine, steroids, norepinephrine transporter inhibitors, ergot derivatives. Antagonized by alpha-adrenergic antagonists, PDE-5 inhibitors, mixed alpha- and beta-receptor antagonists, calcium channel blockers (eg, nifedipine), benzodiazepines, ACE inhibitors, reserpine, guanfacine.

Biorphen Adverse Reactions

Adverse Reactions

Nausea, vomiting, headache; vasoconstriction, ischemia, severe bradycardia, renal toxicity.

Biorphen Clinical Trials

See Literature

Biorphen Note

Not Applicable

Biorphen Patient Counseling

See Literature